Hunter Associates Investment Management LLC Eli Lilly & CO Transaction History

Hunter Associates Investment Management LLC

$595 Million
Q2 2024

A detailed history of Hunter Associates Investment Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 8,896 shares of LLY stock, worth $8.09 Million. This represents 1.35% of its overall portfolio holdings.

Number of Shares

8,896

Previous 10,026 11.27%

Holding current value

$8.09 Million

Previous $7.8 Million 3.24%

% of portfolio

1.35%

Previous 1.31%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $819,103 - $1.03 Million	-1,130 Reduced 11.27%	8,896 $8.05 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $75,102 - $88,535	-143 Reduced 1.41%	10,026 $5.84 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $29,994 - $41,351	69 Added 0.68%	10,169 $5.46 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $159,235 - $212,916	454 Added 4.71%	10,100 $4.74 Million
Q4 2022 Feb 01, 2023	BUY	$321.55 - $374.67 $48,232 - $56,200	150 Added 1.58%	9,646 $3.53 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $53,366 - $60,816	180 Added 1.93%	9,496 $3.07 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2.54 Million - $2.98 Million	-9,112 Reduced 49.45%	9,316 $3.02 Million
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $388,540 - $482,181	-1,728 Reduced 8.57%	18,428 $5.09 Million
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $1.59 Million - $2.06 Million	8,833 Added 78.01%	20,156 $4.63 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $56,361 - $72,962	343 Added 3.12%	11,323 $2.12 Million
Q4 2020 Jan 29, 2021	SELL	$130.46 - $172.63 $143,506 - $189,893	-1,100 Reduced 9.11%	10,980 $1.85 Million
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $8,773 - $10,147	60 Added 0.5%	12,080 $1.79 Million
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $833 - $1,031	7 Added 0.06%	12,020 $1.67 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $117,612 - $145,673	1,100 Added 10.08%	12,013 $1.58 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $11,131 - $13,102	-100 Reduced 0.91%	10,913 $1.42 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $8,163 - $9,636	110 Added 1.01%	11,013 $852,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $840,294 - $932,642	10,903	10,903 $933,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.

Account

Hunter Associates Investment Management LLC Eli Lilly & CO Transaction History